Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on June 13, 2017. The report discloses corporate governance changes, specifically the appointment of a new director and associated compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Appointment: Amit Munshi was appointed as a Class I director and a member of the audit committee, effective June 13, 2017.
- Compensatory Arrangement: Mr. Munshi was granted a stock option to purchase 8,800 shares of common stock.
- Option Terms: The exercise price equals the fair market value on the grant date. The term is ten years.
- Vesting Schedule: One-fourth of the option vests on the first anniversary of the grant date. The remaining balance vests monthly at a rate of 2.083% over the subsequent 36 months, contingent on continued service.
Outlook, Risks, and Unusual Items
The filing references a press release issued on June 15, 2017, regarding the appointment. No specific guidance, outlook, risks, or unusual financial items are detailed within the text of this 8-K.
Investor Verification Checklist
- Verify the fair market value of the stock on June 13, 2017, to determine the exercise price of the granted options.
- Review the Pulmatrix, Inc. 2013 Employee, Director and Consultant Equity Incentive Plan for specific terms governing the grant.
- Confirm the total number of outstanding shares and the dilution impact of the 8,800 new options.
- Check the press release (Exhibit 99.1) for additional context on Mr. Munshi's qualifications and the strategic rationale for the appointment.